Increased rates of spontaneous sister chromatid exchange in lymphocytes of BRCA2+/- carriers of familial breast cancer clusters

Cancer Letters

Volumn 210, Issue 1, 2004, Pages 85-94

  Kim, Min Kyoung ^a   Zitzmann, Sabine ^a   Westermann, Frank ^a   Arnold, Katrin ^a   Brouwers, Stefan ^a   Schwab, Manfred ^a   Savelyeva, Larissa ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

BRCA2; Familial breast cancer clusters; Fluorescence in situ hybridisation; Haploinsufficiency; Homologous recombination; Sister chromatid exchange

Indexed keywords

BRCA2 PROTEIN; CARRIER PROTEIN;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FAMILIAL CANCER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CLUSTER; GENE FREQUENCY; GENE MUTATION; GENE PROBE; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; METAPHASE CHROMOSOME; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE; WILD TYPE;

BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MALE; METAPHASE; PEDIGREE; SISTER CHROMATID EXCHANGE;

EID: 2542473262     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.01.014     Document Type: Article

References (44)

1. Hoeijmakers J.H. DNA repair mechanisms. Maturitas. 13-22:2001;17-22
2. Duker N.J. Chromosome breakage syndromes and cancer. Am. J. Med. Genet. 115:2002;125-129
3. Collins N., McManus R., Wooster R., Mangion J., Seal S., Lakhani S.R., et al. Consistent loss of the wild type allele in breast cancers from a family linked to the brca2 gene on chromosome 13q12-13. Oncogene. 10:1995;1673-1675
4. Tavtigian S.V., Simard J., Rommens J., Couch F., Shattuck-Eidens D., Neuhausen S., et al. The complete brca2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet. 12:1996;333-337
5. Tirkkonen M., Johannsson O., Agnarsson B.A., Olsson H., Ingvarsson S., Karhu R., Kallioniemi O.P., et al. Distinct somatic genetic changes associated with tumor progression in carriers of brca1 and brca2 germ-line mutations. Cancer Res. 57:1997;1222-1227
6. Patel K.J., Yu V.P., Lee H., Corcoran A., Thistlethwaite F.C., Evans M.J., et al. Involvement of brca2 in DNA repair. Mol. Cell. 1:1998;347-357
7. Sharan S.K., Bradley A. Murine brca2: sequence, map position, and expression pattern. Genomics. 40:1997;234-241
8. Abbott D.W., Freeman M.L., Holt J.T. Double-strand break repair deficiency and radiation sensitivity in brca2 mutant cancer cells. J. Natl. Cancer Inst. 90:1998;978-985
9. Wong A.K., Pero R., Ormonde P.A., Tavtigian S.V., Bartel P.L. Rad51 interacts with the evolutionarily conserved brc motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem. 272:1997;31941-31944
10. Pellegrini L., Yu D.S., Lo T., Anand S., Lee M., Blundell T.L., Venkitaraman A.R. Insights into DNA recombination from the structure of a rad51-brca2 complex. Nature. 420:2002;287-293
11. Cox M.M., Goodman M.F., Kreuzer K.N., Sherratt D.J., Sandler S.J., Marians K.J. The importance of repairing stalled replication forks. Nature. 6773:2000;37-41
12. Davies A.A., Masson J.Y., McIlwraith M.J., Stasiak A.Z., Stasiak A., Venkitaraman A.R., West S.C. Role of brca2 in control of the rad51 recombination and DNA repair protein. Mol. Cell. 7:2001;273-282
13. Jasin M. Homologous repair of DNA damage and tumorigenesis: the brca connection. Oncogene. 21:2002;8981-8993
14. German J., Ellis N.A., Proytcheva M. Bloom's syndrome Xix. Cytogenetic and population evidence for genetic heterogeneity. Clin. Genet. 49:1996;223-231
15. Carrano A.V., Thompson L.H., Lindl P.A., Minkler J.L. Sister chromatid exchange as an indicator of mutagenesis. Nature. 271:1978;551-553
16. Nordenson I., Beckman L., Liden S., Stjernberg N. Chromosomal aberrations and cancer risk. Hum. Hered. 34:1984;76-81
17. Roy S.K., Trivedi A.H., Bakshi S.R., Patel R.K., Shukla P.H., Patel S.J., et al. Spontaneous chromosomal instability in breast cancer families. Cancer Genet. Cytogenet. 118:2000;52-56
18. Cortes-Gutierrez E.I., Cerda-Flores R.M., Leal-Garza C.H. Sister chromatid exchanges in peripheral lymphocytes from women with carcinoma of the uterine cervix. Cancer Genet. Cytogenet. 122:2000;121-123
19. Baltaci V., Kayikcioglu F., Alpas I., Zeyneloglu H., Haberal A. Sister chromatid exchange rate and alkaline comet assay scores in patients with ovarian cancer. Gynecol. Oncol. 84:2002;62-66
20. Sonoda E., Sasaki M.S., Morrison C., Yamaguchi-Iwai Y., Takata M., Takeda S. Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells. Mol. Cell Biol. 19:1999;5166-5169
21. Haber J.E. Partners and pathwaysrepairing a double-strand break. Trends Genet. 16:2000;259-264
22. Savelyeva L., Claas A., Gier S., Schlag P., Finke L., Mangion J., et al. An interstitial tandem duplication of 9p23-24 coexists with a mutation in the brca2 gene in the germ line of three brothers with breast cancer. Cancer Res. 58:1998;863-866
23. Savelyeva L., Claas A., Matzner I., Schlag P., Hofmann W., Scherneck S., et al. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in brca2 mutation carriers. Cancer Res. 61:2001;5179-5185
24. Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum. Genet. 73:1986;320-326
25. Perry P., Wolff S. New giemsa method for the differential staining of sister chromatids. Nature. 251:1974;156-158
26. Wolff S., Perry P. Differential giemsa staining of sister chromatids and the study of chromatid exchanges without autoradiography. Chromosoma. 48:1974;341-353
27. Wojcik A., Opalka B., Obe G. Analysis of inversions and sister chromatid exchanges in chromosome 3 of human lymphocytes exposed to X-rays. Mutagenesis. 14:1999;633-638
28. Johnson R.D., Jasin M. Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells. Eur. Mol. Biol. Org. J. 19:2000;3398-3407
29. Levi-Setti R., Chabala J.M., Gavrilov K., Espinosa R., Le Beau M.M. Advances in high resolution sims studies of brdu-labelled human metaphase chromosomes. Cell Mol. Biol. (Noisy-le-grand). 42:(3rd):1996;301-324
30. Crossen P.E., Drets M.E., Arrighi F.E., Johnston D.A. Aanlysis of the frequency and distribution of sister chromatid exchanges in cultured human lymphocytes. Hum. Genet. 35:1977;345-352
31. Hagmar L., Bonassi S., Stromberg U., Brogger A., Knudsen L.E., Norppa H., Reuterwall C. Chromosomal aberrations in lymphocytes predict human cancer: A report from the european study group on cytogenetic biomarkers and health (esch). Cancer Res. 58:1998;4117-4121
32. Taguchi T., Shiraishi Y. Increased sister-chromatid exchanges (sces) and chromosomal fragilities by brdu in a human mutant b-lymphoblastoid cell line. Mutat. Res. 211:1989;43-49
33. Gutierrez C., Hernandez P., Lopez-Saez J.F. Brdurd-independent and brdurd-dependent sces as components of sce yields: Implications for their cellular significance. Basic Life Sci. 29:1984;83-90
34. Miller K. Sister-chromatid exchange in human b- and t-lymphocytes exposed to bleomycin, cyclophosphamide, and ethyl methanesulfonate. Mutat. Res. 247:1991;175-182
35. Martin R.H., Rademaker A., German J. Chromosomal breakage in human spermatozoa, a heterozygous effect of the bloom syndrome mutation, Am. J. Hum. Genet. 55:1994;1242-1246
36. Gruber S.B., Ellis N.A., Scott K.K., Almog R., Kolachana P., Bonner J.D., et al. Blm heterozygosity and the risk of colorectal cancer. Science. 297:2002;2013
37. Goss K.H., Risinger M.A., Kordich J.J., Sanz M.M., Straughen J.E., Slovek L.E., et al. Enhanced tumor formation in mice heterozygous for blm mutation. Science. 297:2002;2051-2053
38. Kucherlapati M., Yang K., Kuraguchi M., Zhao J., Lia M., Heyer J., et al. Haploinsufficiency of flap endonuclease (fen1) leads to rapid tumor progression. Proc. Natl. Acad. Sci. USA. 99:2002;9924-9929
39. Venkatachalam S., Shi Y.P., Jones S.N., Vogel H., Bradley A., Pinkel D., Donehower L.A. Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation. Eur. Mol. Biol. Org. J. 17:1998;4657-4667
40. Spring K., Ahangari F., Scott S.P., Waring P., Purdie D.M., Chen P.C., et al. Mice heterozygous for mutation in atm, the gene involved in ataxia- telangiectasia, have heightened susceptibility to cancer. Nat. Genet. 32:2002;185-190
41. Scully R., Puget N., Vlasakova K. DNA polymerase stalling, sister chromatid recombination and the brca genes. Oncogene. 19:2000;6176-6183
42. Venkitaraman A.R. Chromosome stability, DNA recombination and the brca2 tumour suppressor. Curr. Opin. Cell Biol. 13:2001;338-343
43. Moynahan M.E., Cui T.Y., Jasin M. Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a brca1 mutation. Cancer Res. 61:2001;4842-4850
44. Lupski J.R. Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet. 14:1998;417-422